These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9417052)

  • 1. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity.
    Langley E; Kemppainen JA; Wilson EM
    J Biol Chem; 1998 Jan; 273(1):92-101. PubMed ID: 9417052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.
    Langley E; Zhou ZX; Wilson EM
    J Biol Chem; 1995 Dec; 270(50):29983-90. PubMed ID: 8530400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
    Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
    Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains.
    Wong CI; Zhou ZX; Sar M; Wilson EM
    J Biol Chem; 1993 Sep; 268(25):19004-12. PubMed ID: 8360187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.
    Zhou ZX; Sar M; Simental JA; Lane MV; Wilson EM
    J Biol Chem; 1994 May; 269(18):13115-23. PubMed ID: 8175737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
    He B; Kemppainen JA; Wilson EM
    J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
    Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
    Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of androgen receptor binding to selective androgen response elements.
    Shaffer PL; Jivan A; Dollins DE; Claessens F; Gewirth DT
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4758-63. PubMed ID: 15037741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of different androgen receptor domains to receptor dimerization and signaling.
    Centenera MM; Harris JM; Tilley WD; Butler LM
    Mol Endocrinol; 2008 Nov; 22(11):2373-82. PubMed ID: 18617596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain.
    He B; Kemppainen JA; Voegel JJ; Gronemeyer H; Wilson EM
    J Biol Chem; 1999 Dec; 274(52):37219-25. PubMed ID: 10601285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepwise androgen receptor dimerization.
    van Royen ME; van Cappellen WA; de Vos C; Houtsmuller AB; Trapman J
    J Cell Sci; 2012 Apr; 125(Pt 8):1970-9. PubMed ID: 22328501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.
    Haelens A; Verrijdt G; Callewaert L; Christiaens V; Schauwaers K; Peeters B; Rombauts W; Claessens F
    Biochem J; 2003 Jan; 369(Pt 1):141-51. PubMed ID: 12350223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.